Business

BeautyHealth’s Hydrafacial Announces Partnership to Develop Breakthrough Exosome Booster

Co-Created with Organicell, the first-to-market booster will address aging and inflammation through regenerative technology LONG BEACH, Calif.--(BUSINESS

articleSkinhealth Systems Inc.September 14, 20225/company/beauty-health-co/news/beautyhealths-hydrafacial-announces-partnership-to-develop-breakthrough-exosome-booster
BeautyHealth’s Hydrafacial Announces Partnership to Develop Breakthrough Exosome Booster

About this update from Skinhealth Systems Inc.

[{"type":"text","content":"\nCo-Created with Organicell, the first-to-market booster will address aging and inflammation through regenerative technology\n\n LONG BEACH, Calif.--(BUSINESS WIRE)--\nThe Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced a collaboration with biotech company Organicell to co-create a first-to-market exosome booster that will address signs of aging and inflammation in the skin. The booster will leverage novel exosome technology based on regenerative medical therapies and, once developed, will be available as a customized treatment addition for Hydrafacial.\n\n“We are excited to begin development with Organicell to co-create a potentially skin-changing Hydrafacial booster based on their breakthrough exosome technology,” said BeautyHealth President and Chief Executive Officer Andrew Stanleick. “This partnership builds on our lineup of boosters and is the perfect example of the power of co-creation in our R&D model, which gives us access to the most novel technologies and formulas and translates them to market on an accelerated timetable.”\n\nExosomes are small membrane vesicles, which are among the most productive and conducive to wound healing and countering inflammation. These benefits will help treat the skin and address signs of aging when delivered as a booster through Hydrafacial’s exceptional delivery system.\n\nThe exosomes in Organicell’s technology contain over 300 cytokines, chemokines and growth factors harvested under cGMP conditions that will allow Hydrafacial to put billions of exosomes in each booster vial. Within the booster, they will promote cellular communication, repair and regeneration to address signs of aging and inflammation like never before.\n\nOrganicell CEO Matt Sinnreich said, “Organicell is honored to pair our science team with Hydrafacial’s formulators to help create a booster that not only pioneers a new technology but could potentially change the facial industry forever.”\n\nThis collaboration marks a major advancement in Hydrafacial’s booster strategy, which is centered around partnerships and co-creation. Today Hydrafacial has a lineup of 20 boosters, the majority co-created with fellow skincare brands such as Murad, ZO and JLo Beauty.\n\nHydrafacial’s co-creation model can deliver a booster in under six months, a fraction of the time typically required to ...

More updates from Skinhealth Systems Inc.